Geneos Wealth Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-345
Closed -$9.86K 2740
2025
Q2
$9.86K Sell
345
-623
-64% -$16.7K ﹤0.01% 2335
2025
Q1
$24.1K Buy
968
+768
+384% +$18.3K ﹤0.01% 2245
2024
Q4
$4.53K Sell
200
-205
-51% -$4.45K ﹤0.01% 2373
2024
Q3
$8.63K Buy
+405
New +$7.97K ﹤0.01% 1891
2018
Q3
Sell
-201
Closed -$10K 2416
2018
Q2
$10K Buy
+201
New +$10.2K ﹤0.01% 1716
2017
Q1
Sell
-65
Closed -$2K 2086
2016
Q4
$2K Hold
65
﹤0.01% 1853
2016
Q3
$2K Buy
+65
New +$2.91K ﹤0.01% 1773

Other funds holding FMS

Geneos Wealth Management's FMS Position: Q3 2025 in Review

Geneos Wealth Management sold out of Fresenius Medical Care (FMS) in Q3 2025, closing a stake of 345 shares — an estimated $9.86K sold.

Geneos Wealth Management first reported a position in FMS in Q3 2016 and held it in 7 quarters. The position peaked at $24.1K in Q1 2025. 205 funds tracked by Wall St. Rank hold FMS as of Q3 2025.

  • Geneos Wealth Management reported no remaining Fresenius Medical Care position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 345 Fresenius Medical Care shares in Q3 2025, an estimated $9.86K.
  • Geneos Wealth Management first reported a position in Fresenius Medical Care in Q3 2016 and held it in 7 quarters.
  • Geneos Wealth Management's Fresenius Medical Care position peaked at $24.1K in Q1 2025.
  • 205 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.